Iterum Therapeutics plc (ITRM)

NGM – Real vaqt narxi. Valyuta: USD

0.03

+0.03 (0.00%)

Yopilishda: Mar 31, 2026, 4:00 PM EDT

27.03.2026

Iterum files wind-up petition due to limited cash, inability to raise equity

Iterum Therapeutics said on Friday it has filed a petition in Ireland's High Court to wind up the drugmaker and was placed ‌into provisional liquidation, with a hearing set for April 13.

27.03.2026

Iterum Therapeutics Announces Filing of Winding Up Petition

DUBLIN and CHICAGO, March 27, 2026 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (in Provisional Liquidation) (Nasdaq: ITRM) (the “Company” or “Iterum” or “we”), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today announced that it has filed a petition in the High Court in Ireland to wind up the Company. An Order was made appointing Damien Murran and Jennifer McMahon, each of Teneo Restructuring (Ireland) Limited (the “Joint Provisional Liquidators”), as Joint Provisional Liquidators to the Company.

13.02.2026

Iterum Therapeutics Provides Business Update

--Expanded Market Access and Patent Protection for ORLYNVAH™ --FDA correspondence regarding the use of ORLYNVAH™ as step-down therapy DUBLIN and CHICAGO, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company” or “Iterum” or “we”), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today provided a business update. Recent Events Market Access Update: Medicare Part D Milestone: We are pleased to announce another signed rebate agreement with one of the top three Medicare Part D Pharmacy Benefit Managers, in addition to our existing agreements with the other two of the top three.

23.12.2025

Iterum Therapeutics Provides Business Update

DUBLIN and CHICAGO, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company” or “Iterum” or “we”), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today provided a business update. Recent Events Market Access Update: Payor Reimbursement and Contracting Expands with Major PBM Agreement: ORLYNVAH™'s market access continues to accelerate.

17.12.2025

Iterum Therapeutics Provides Business Update

DUBLIN and CHICAGO, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company” or “Iterum” or “we”), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today provided a business update. Recent Events Market Access Update: Payor Reimbursement and Contracting Expands with Major PBM Agreement: ORLYNVAH™'s market access continues to accelerate.

05.12.2025

Iterum Therapeutics Provides Business Update

DUBLIN and CHICAGO, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company” or “Iterum” or “we”), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today provided a business update.

24.11.2025

Iterum Therapeutics Provides Business Update

DUBLIN, Ireland and CHICAGO, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company” or “Iterum”), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today provided a business update. Recent Events Specialty Distributor Now Stocked: ORLYNVAH™ is now available at McKesson, which will allow certain physicians the ability to procure the product directly from McKesson through this specialty distribution channel, consistent with their practice preferences.

Videolar

No Data

There is no data to display

Iterum Therapeutics plc (ITRM)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Iterum Therapeutics plc (ITRM)

Iterum files wind-up petition due to limited cash, inability to raise equity

Iterum Therapeutics Announces Filing of Winding Up Petition

Iterum Therapeutics Provides Business Update

Iterum Therapeutics Provides Business Update

Iterum Therapeutics Provides Business Update

Iterum Therapeutics Provides Business Update

Iterum Therapeutics Provides Business Update

Videolar

No Data

Press-relizlar

Iterum Therapeutics Announces Filing of Winding Up Petition

Iterum Therapeutics Provides Business Update

Iterum Therapeutics Provides Business Update

Iterum Therapeutics Provides Business Update

Iterum files wind-up petition due to limited cash, inability to raise equity

Iterum Therapeutics Announces Filing of Winding Up Petition

Iterum Therapeutics Provides Business Update

Iterum Therapeutics Provides Business Update

Iterum Therapeutics Provides Business Update

Iterum Therapeutics Provides Business Update

Iterum Therapeutics Provides Business Update

Videolar

No Data

Press-relizlar

Iterum Therapeutics Announces Filing of Winding Up Petition

Iterum Therapeutics Provides Business Update

Iterum Therapeutics Provides Business Update

Iterum Therapeutics Provides Business Update

Search stocks

Iterum Therapeutics plc (ITRM)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Iterum Therapeutics plc (ITRM)

Iterum files wind-up petition due to limited cash, inability to raise equity

Iterum Therapeutics Announces Filing of Winding Up Petition

Iterum Therapeutics Provides Business Update

Iterum Therapeutics Provides Business Update

Iterum Therapeutics Provides Business Update

Iterum Therapeutics Provides Business Update

Iterum Therapeutics Provides Business Update

Videolar

No Data

Press-relizlar

Iterum Therapeutics Announces Filing of Winding Up Petition

Iterum Therapeutics Provides Business Update

Iterum Therapeutics Provides Business Update

Iterum Therapeutics Provides Business Update

Iterum files wind-up petition due to limited cash, inability to raise equity

Iterum Therapeutics Announces Filing of Winding Up Petition

Iterum Therapeutics Provides Business Update

Iterum Therapeutics Provides Business Update

Iterum Therapeutics Provides Business Update

Iterum Therapeutics Provides Business Update

Iterum Therapeutics Provides Business Update

Videolar

No Data

Press-relizlar

Iterum Therapeutics Announces Filing of Winding Up Petition

Iterum Therapeutics Provides Business Update

Iterum Therapeutics Provides Business Update

Iterum Therapeutics Provides Business Update